|
|
|
|
Causes of Neuroblastoma
|
|
The causes of neuroblastoma are generally
unknown to health care providers. While it is
understood what neuroblastoma is, the exact
causes have been unsuccessfully researched since
the first case of neuroblastoma was detected.
There are many studies and clinical trials
currently being conducted in order to find out
more about what exactly causes the disease. In a
new fetus and once the human is born, there are
many regular cells that grow and divide, |
|
|
but these cells known when to stop growing.
Cancer cells do not know when to stop, and continue to
grow and divide at an uncontrollable rate. When there
are many of these cells that do not know when to stop
growing, they form a tumor. In every living being, there
are undeveloped nerve cells that are called neuroblasts. The adrenal glands in a human are
made up in part by neuroblasts, once they grow
and develop into nerve cells and filaments that
make up the glands. The process of neuroblasts
growing into nerves is supposed to occur by the
time the human is born. The neuroblasts that do
not either grow into nerves and fibers, or just
disappear, are the ones that become cancerous.
In some cases neuroblastoma can be inherited.
Mutations, or DNA that alters it's form, can
cause neuroblastoma. Oncogenes are genes that
increase the speed in which cells grow and
divide. Tumor suppressor genes are genes that
decrease the speed in which cells grow and
divide. Many studies have suggested that
patients with neuroblastoma are believed to have
more oncogenes than normal, as well as tumor
suppressor genes that do not act the same way
they do in those who do not have neuroblastoma.
While there is some information that suggests
how and why certain cases of neuroblastoma
start, health care providers, medical experts
and researchers of the disease do not currently
know exactly how the disease is caused. Current
neuroblastoma research is very involved with
finding answers to these questions. |
|
Symptoms:
Neuroblastoma symptoms are
mainly caused by the
cancer
cells, or the tumor, putting pressure on
tissue that surrounds them while growth
is occurring. While some of the
neuroblastoma symptoms are unique, they
can be due to a different
infection
or disease. Therefore, if any of the
neuroblastoma symptoms occur, patients
should be seen by a doctor as soon as
possible. There are many symptoms of
neuroblastoma that are common, while
other symptoms may be more uncommon to
certain patients. The types and amount
of symptoms depend on how advanced the
cancer
is. Common neuroblastoma symptoms: |
|
An abnormal cluster appearing on
the skin above the abdomen area, neck or above
the stomach. Some lumps may be painful, while
others are not. Appendage
of the eyes, which usually results in pain in
the eyes and surrounding skin.
Aches and/or discomfort in the bones.
In newborns, it is common for
neuroblastoma patients to feel pain and
tenderness in the stomach, which can make it
hard for the patient to breath.Some
neuroblastoma patients have reported the
inability to move certain organs of the
body. |
|
Uncommon symptoms of
neuroblastoma that have been reported:
Since
the stress of some symptoms is much more
intense on an infant's
body than a grownadult,
the neuroblastoma patient will commonly obtain a
raised
body
temperature. Excessive
tiredness. Since
an infant's, or young child's skin and
muscles are not as strong as a fully
developed human's, it make it easier for a
neuroblastoma patient to bruise and draw
blood.
Neuroblastoma
patients often have a raised blood pressure,
which is most likely due to the high amount
of stress that the
body is experiencing.
Extremely
wet and non-solid bowel movements. This is
probably due to the pain and discomfort that
often occurs in a neuroblastoma patient's
stomach.
A less commonly
reported symptom is the compulsive and
uncontrollable movement of certain muscles. Unintended,
or undesired, movement of the eyes.Tenderness
growth in certain muscles and organs
below the waist |
|
Neuroblastoma Diagnosis:
A
neuroblastoma diagnosis is obtained by
detecting the disease through various
methods of screening. Once neuroblastoma is
positively identified, the health care
provider can determine what stage the
cancer
is in and how aggressive it is and may
become. If a child is experiencing common
symptoms of neuroblastoma, it is important
that they undergo neuroblastoma screening.
Many of the common symptoms of neuroblastoma
can also be symptoms of other
infection and
diseases, that are usually less severe. |
|
Urine Test:
The
most commonly used method of neuroblastoma
screening is a urine test. Neuroblastoma
cancer cells release vanillyl mandellic
acid, or VMA. Therefore, if vanillyl
mandellic acid is found in the patient's
urine, then they most likely have
neuroblastoma. Also, if the patient has a
higher then normal level of catecholamines
in their blood or urine, nine times out of
ten, that indicates that they have
neuroblastoma. If these chemicals are
present in the patient's urine, the health
care provider will usually call for further
testing, as opposed to diagnosing
neuroblastoma based on the urine or blood
tests alone. |
|
Imaging Tests:
MRI and CT
scans are commonly used to detect neuroblastoma. These types of scans provide
health care providers with detailed images
of inside the patient's
body. The CT scan
uses X ray technology to produce internal
images of the
body. The MRI scan works by
sending radio waves into the patient and
magnets are used to produce images of the
patient's
body. If neuroblastoma
cancer
exists in the patients, either the MRI scan
or CT scan will clearly show this. Many
times an ultrasound is used to detect
neuroblastoma. The ultrasound uses a
transducer, which is a tool that can convert
a certain type of energy into a different
form of energy. The transducer sends out
sound waves, which bounce off of organs in
the
body, and as a result, it produces live
images. These live images are viewed on the
screen that is attached to the ultrasound
machine. |
Biopsy:
A most important method used in neuroblastoma diagnosis is a biopsy. A
biopsy can be conducted with bone marrow or
lymph nodes. In either case, a sample of
either bone marrow or lymph nodes are
surgically removed from the patient. The
sample is then examined under a microscope
where the health care provider can determine
whether or not there are any abnormalities
present. Another way to detect neuroblastoma
is to administer a chemical known as
metaiodobenzylguanidine, intravenously into
the patient. One full day after the drug is
put into the patient's
body, the level of
the chemical is checked. If there is a low
level of the chemical, that most likely
indicates that the neuroblastoma
cancer
cells have absorbed it, which means that the
patient has neuroblastoma. The next part of
the neuroblastoma diagnosis is to stage the
cancer. Neuroblastoma is usually identified
by one of the four main stages (Stage 1-4).
However, for neuroblastoma patients that are
under the age of one year old, there is a
stage called 4S (S is for special) which is
designated for unique forms of neuroblastoma
cancer.
Once neuroblastoma is identified and the
stage of the
cancer is determined, the
disease is categorized. A local resectable
case of neuroblastoma means that the
cancer
is small, has not grown from where it
originated, and can be surgically removed. A
localized unresectable case of neuroblastoma
means that the
cancer is still where it
originated, but can not be removed through
surgery. A regional case of the disease
indicates that it has grown into the nearby
lymph system and close by organs and tissue.
However, at this point, metastasis has not
yet occurred. Once neuroblastoma has been
positively detected and the stage or
category of the disease has been determined,
a proper diagnosis can be given. The
diagnosis will inform the patient of their
situation in regards to have advanced their
case of
cancer is. |
Neuroblastoma Survival Rate:
All statistics regarding
neuroblastoma survival rates
such be taken with a grain
of salt. Like most cancers,
the disease is difficult to
predict, in terms of growth
and aggressiveness. However,
neuroblastoma is one of the
most unpredictable types of
cancer. There have been many
cases of this disease where
it has stopped growing on
it's own and has also grown
rapidly on it's own as well.
While the general neuroblastoma survival rate
is usually high, factors
that influence the
neuroblastoma survival rate
include when the disease is
detected, what stage the
disease is in, the
aggressiveness of the
cancer, the age of the
patient and their medical
history. Since neuroblastoma
only occurs in fetuses and
children up to ten years of
age, there is usually not
much of a medical history
that affects the
neuroblastoma rate. However,
many babies can be born with
inherited genes that make
them prone to certain
physical weaknesses and
strengths.
It
can also be very challenging to
determine and identify whether a
cancer exists or not, and how
advanced the
cancer is without using
certain screening methods because in
many cases, the child is not able to
speak. Therefore, the patient can
not communicate what symptoms he or
she feels. This greatly affects the neuroblastoma survival rate. If a
woman feels a lump on one of their
breasts or feels common symptoms of
breast
cancer, they will know to go
to their health care provider to get
screened for breast
cancer. Since
all neuroblastoma patients are very
young, if they feel common symptoms
of neuroblastoma, they can not
translate what they are feeling into
words. This causes many cases of
Neuroblastoma to go undetected for
long periods of time, making it
harder for health care providers to
treat the disease successfully. The
Neuroblastoma survival rate mainly
depends on what stage the disease is
detected. If the disease is detected
in the first stage, nine out of ten
cases can be treated successfully,
regardless of the patient's age.
About three out of four patients are
able to be cured from the disease if
it is detected during the second
stage of the disease. However, stage
does play a role in the survival
rate during the second stage. About
half of patients older than the age
of one can be cured from
Neuroblastoma if it is detected
during the third stage of the
disease. If the disease is detected
during either stage four or 4S, and
the patient is under one year old,
their is a 50/50 chance that they
will survive. However, if the
patient is older than one year old,
then their chances of survival are
dramatically reduced to about ten to
forty percent.
There are many factors that play a
role in the Neuroblastoma survival
rate. This is why statistics of the
survival rate are estimated and are
not as black and white as statistics
of other diseases. |
|
|
|
|
|
|